↓ Skip to main content

Prophylactic and therapeutic DNA vaccines against Chagas disease

Overview of attention for article published in Parasites & Vectors, February 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter
4 X users
facebook
2 Facebook pages

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
97 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prophylactic and therapeutic DNA vaccines against Chagas disease
Published in
Parasites & Vectors, February 2015
DOI 10.1186/s13071-015-0738-0
Pubmed ID
Authors

Minerva Arce-Fonseca, Martha Rios-Castro, Silvia del Carmen Carrillo-Sánchez, Mariana Martínez-Cruz, Olivia Rodríguez-Morales

Abstract

Chagas disease is a zoonosis caused by Trypanosoma cruzi in which the most affected organ is the heart. Conventional chemotherapy has a very low effectiveness; despite recent efforts, there is currently no better or more effective treatment available. DNA vaccines provide a new alternative for both prevention and treatment of a variety of infectious disorders, including Chagas disease. Recombinant DNA technology has allowed some vaccines to be developed using recombinant proteins or virus-like particles capable of inducing both a humoral and cellular specific immune response. This type of immunization has been successfully used in preclinical studies and there are diverse models for viral, bacterial and/or parasitic diseases, allergies, tumors and other diseases. Therefore, several research groups have been given the task of designing a DNA vaccine against experimental infection with T. cruzi. In this review we explain what DNA vaccines are and the most recent studies that have been done to develop them with prophylactic or therapeutic purposes against Chagas disease.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 2 2%
Brazil 1 1%
Unknown 94 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 15%
Student > Ph. D. Student 13 13%
Student > Master 11 11%
Researcher 10 10%
Student > Doctoral Student 6 6%
Other 18 19%
Unknown 24 25%
Readers by discipline Count As %
Agricultural and Biological Sciences 20 21%
Biochemistry, Genetics and Molecular Biology 16 16%
Medicine and Dentistry 11 11%
Immunology and Microbiology 9 9%
Chemistry 5 5%
Other 12 12%
Unknown 24 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2015.
All research outputs
#13,373,196
of 23,577,654 outputs
Outputs from Parasites & Vectors
#2,233
of 5,581 outputs
Outputs of similar age
#117,772
of 256,820 outputs
Outputs of similar age from Parasites & Vectors
#28
of 112 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,581 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 256,820 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 112 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.